MARKET WIREReuters • 2h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
Why ETON Stock surged +3.61% Today — RQD Quant Desk Flash
$53.67 +3.61% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $53.92
Eton Pharmaceuticals Inc. (ETON) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
ROARABLE C • HOLD / WATCH
Cap $1.53B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $53.92 (+0.46%)🧬 Dilution Drag (+1.64% YoY Shares)⚙️ Cash Engine: 13/20 (C) • 12.7% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 62/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.7% avg 90D alpha vs SPY • 54.3% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERHOLD / WATCH • C
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D+ · Rk B
Each axis scored 0–20
12M PRICE TARGET CONE+1.8% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ETON)Realized 20D OHLCV Swing Band: ±9.8%
Deterministic 5-Pillar Attribution (62/100 Composite)
🔍 WHY ETON SCORES 62/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (26% of score)
Altman Z-Score 13.37 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
▲ #2 Bullish Driver: Whale & Options Positioning+14/20 pts (23% of score)
20D Institutional Volume Accumulation (±9.8% realized swing band)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution6/20 pts (-14 pt drag)
Dilution Drag (+1.64% YoY Shares) & executive Form 4 sales trim 14 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade B$55.21-8.9% Next Q
70
Q2 (-2Q)Grade B-$50.31-0.6% Next Q
67
Q3 (-1Q)Grade C+$50.00+7.3% Next Q
65
CurrentGrade C$53.67+0.7% Hist 90D α
62
Trajectory: B (70) → C (62)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the ETON Bull Thesis Could Fail
Even with a 62/100 (C) score, ETON faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Company executives have done more routine share selling than personal cash buying lately.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Dilution Drag (+1.64% YoY Shares) — any gross margin slip below 51.0% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($56.00) or 200D SMA ($35.71) invalidates the momentum regime and cuts Target Base ($54.64) toward Bear Floor ($42.62).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $ETON• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ETON Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why ETON Stock surged +3.61% Today — RQD Quant Desk Flash
Eton Pharmaceuticals Inc. (ETON) surged +3.61% to $53.67, trading at 76% of its 52-week range ($14.27 – $66.37). Solid 54% profit margin (-1% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 76% of its 52-week range ($14.27 – $66.37) with RSI-14 at 47.9 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±9.8% around $53.67 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C (Hold) backed by 53.5% gross margin and $10.2M annual free cash flow.
Live ETON Headlines & Catalysts
MARKET WIRECNBC • 4h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 4h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 6h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 7h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 8h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 8h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 9h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (ETON Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ETON // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +122.51%🛡️ HOLDING TREND SUPPORT
2026-10-30O $53.33H $53.67L $51.89C $53.67VOL 335.7K
RES: $71.01SUP: $50.10SMA50: $56.00SMA200: $35.71
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
ETON Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +104.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on ETON today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for ETON. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ETON today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ETON)
Health Care Rank #169 of 1016
⚔️ INVA vs ETON Full Matrix →
1. Head-to-Head Health Care Peer Comparison (ETON vs. INVA, GPCR, PAHC, TYRA)
Industry: Biotechnology: Pharmaceutical Preparations (489 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Eton Pharmaceuticals Inc. (ETON) ranks #169 by composite RQD confidence (62/100, grade C) and #303 by equity capitalization ($1.53B). Within this direct 5-issuer industry benchmark cohort, PAHC leads on earnings valuation at 32.7x trailing P/E, while INVA leads on capital efficiency and profitability with 14.7% ROIC and 74.8% gross margin. INVA currently holds the highest overall quantitative score in the immediate peer group at 75/100 (B) compared with ETON at 62/100 (C).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ETON
ACTIVE
Eton Pharmaceuticals Inc. | C | 62/100 | — | 53.5% | -0.9% | +3.61% | $1.53B | Benchmark Subject |
| INVA Innoviva Inc. | B | 75/100 | — | 74.8% | 14.7% | +0.90% | $1.54B | /inva-vs-eton → |
| GPCR Structure Therapeutics Inc. | D- | 42/100 | — | — | -19.5% | +2.14% | $1.56B | /gpcr-vs-eton → |
| PAHC Phibro Animal Health Corporation (Class A) | C+ | 68/100 | 32.7x | 30.9% | 9.9% | +2.59% | $1.58B | /pahc-vs-eton → |
| TYRA Tyra Biosciences Inc. | D- | 41/100 | — | — | -35.0% | -1.24% | $1.48B | /tyra-vs-eton → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001710340In its most recent audited fiscal period (FY2025, filed 2025-12-31), Eton Pharmaceuticals Inc. (ETON) reported GAAP revenue of $80.0M (+104.9% vs. FY2024 revenue of $39.0M , and +152.7% cumulative change since FY2023) , GAAP net income of -$4.6M, operating cash flow of $10.5M, and free cash flow of $10.2M (+980.7% YoY). On the balance sheet, ETON closed FY2025 with $92.1M in total assets against $21.8M in total debt (Altman Z-Score: 13.37, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $80.0M | -$4.6M | $10.5M | $10.2M | $92.1M | $21.8M |
| FY2024 (FY) | 2024-12-31 | $39.0M | -$3.8M | $969.0K | $943.0K | $76.1M | $29.8M |
| FY2023 (FY) | 2023-12-31 | $31.6M | -$936.0K | $6.8M | $6.8M | — | — |
3. ETON Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ETON stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Eton Pharmaceuticals Inc. (NASDAQ: ETON) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 62/100 at a spot price of $53.67 (+3.61% 1D, market cap $1.53B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 6/20. Across 1016 tracked Health Care issuers, ETON ranks #169 in composite RQD confidence.
How does ETON compare to INVA and GPCR in the Health Care sector?
Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), ETON carries a Roarable C (62/100 RQD), trailing P/E of N/A, gross margin of 53.5%, and ROIC of -0.9%. By comparison, INVA (Innoviva Inc.) holds a B grade (75/100 RQD, P/E N/A, ROIC 14.7%, cap $1.54B) and GPCR (Structure Therapeutics Inc.) posts a D- grade (42/100 RQD, P/E N/A, ROIC -19.5%, cap $1.56B). Among the 5-stock peer group, PAHC leads on earnings multiple (32.7x) while INVA leads on capital efficiency (14.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ETON?
Per ETON's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001710340), Eton Pharmaceuticals Inc. generated $80.0M in revenue (+104.9% YoY), -$4.6M in net income, and $10.2M in free cash flow against $92.1M in total assets and $21.8M in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ETON trading relative to its 50-day, 200-day, and 52-week technical levels?
ETON last traded at $53.67 (+3.61% on volume of 369,485 shares), positioning the stock -4.16% below its 50-day simple moving average ($56.00) and +50.29% above its 200-day simple moving average ($35.71). Across its 52-week range of $14.27 to $66.37, ETON sits at the 75.6% percentile with a 14-day RSI of 47.9 (NEUTRAL RANGE) and an implied next-earnings move of ±9.8% ($48.41 to $58.93).
ETON Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ETON stock moving today?
Why ETON Stock surged +3.61% Today — RQD Quant Desk Flash. Solid 54% profit margin (-1% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.